CTC
IBDQ

Central Trust Company’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Central Trust Company’s Portfolio IBDQ Stock Details IBDQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-477,667
Closed -$12M – 1588
2025
Q3 		$12M Sell
477,667
-4,753
-1% -$119K 0.25% 69
2025
Q2 		$12.1M Sell
482,420
-106,622
-18% -$2.68M 0.28% 63
2025
Q1 		$14.8M Sell
589,042
-68,163
-10% -$1.71M 0.36% 56
2024
Q4 		$16.5M Buy
657,205
+20,461
+3% +$513K 0.4% 56
2024
Q3 		$16M Buy
636,744
+105,857
+20% +$2.64M 0.37% 56
2024
Q2 		$13.2M Buy
530,887
+60,878
+13% +$1.51M 0.32% 62
2024
Q1 		$11.7M Buy
470,009
+16,817
+4% +$416K 0.29% 69
2023
Q4 		$11.2M Buy
453,192
+66,463
+17% +$1.63M 0.3% 69
2023
Q3 		$9.42M Buy
386,729
+7,823
+2% +$191K 0.27% 73
2023
Q2 		$9.24M Sell
378,906
-155,383
-29% -$3.8M 0.26% 75
2023
Q1 		$13.1M Sell
534,289
-13,317
-2% -$325K 0.38% 54
2022
Q4 		$13.3M Buy
547,606
+38,728
+8% +$938K 0.41% 54
2022
Q3 		$12.3M Buy
508,878
+79,832
+19% +$1.97M 0.42% 52
2022
Q2 		$10.6M Buy
429,046
+56,004
+15% +$1.39M 0.35% 63
2022
Q1 		$9.42M Buy
373,042
+1,592
+0.4% +$41.1K 0.27% 75
2021
Q4 		$9.81M Buy
371,450
+2,547
+0.7% +$67.7K 0.28% 79
2021
Q3 		$9.9M Buy
368,903
+2,349
+0.6% +$63.4K 0.35% 66
2021
Q2 		$9.89M Buy
366,554
+3,656
+1% +$98.7K 0.36% 66
2021
Q1 		$9.74M Buy
362,898
+870
+0.2% +$23.6K 0.38% 60
2020
Q4 		$9.91M Buy
362,028
+5,787
+2% +$157K 0.41% 59
2020
Q3 		$9.66M Buy
356,241
+6,575
+2% +$179K 0.44% 59
2020
Q2 		$9.43M Buy
349,666
+60,620
+21% +$1.59M 0.47% 53
2020
Q1 		$7.22M Buy
289,046
+19,236
+7% +$496K 0.44% 53
2019
Q4 		$7M Buy
269,810
+38,015
+16% +$984K 0.36% 66
2019
Q3 		$6M Buy
231,795
+49,800
+27% +$1.28M 0.34% 71
2019
Q2 		$4.63M Buy
181,995
+69,690
+62% +$1.74M 0.26% 91
2019
Q1 		$2.79M Buy
112,305
+7,300
+7% +$178K 0.17% 135
2018
Q4 		$2.48M Buy
105,005
+200
+0.2% +$4.73K 0.16% 133
2018
Q3 		$2.51M Buy
104,805
+2,300
+2% +$55.2K 0.15% 140
2018
Q2 		$2.45M Buy
102,505
+6,650
+7% +$159K 0.16% 140
2018
Q1 		$2.33M Buy
95,855
+38,525
+67% +$942K 0.15% 143
2017
Q4 		$1.44M Buy
+57,330
New +$1.44M 0.09% 199

Other funds holding IBDQ

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
BL
Balentine LLC Atlanta, Georgia $2.48B AUM 17.44% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Central Trust Company's IBDQ Position: Q4 2025 in Review

Central Trust Company sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 477,667 shares — an estimated $12M sold.

Central Trust Company first reported a position in IBDQ in Q4 2017 and held it in 32 quarters. The position peaked at $16.5M in Q4 2024. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

  • Central Trust Company reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
  • Central Trust Company sold 477,667 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $12M.
  • Central Trust Company first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q4 2017 and held it in 32 quarters.
  • Central Trust Company's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $16.5M in Q4 2024.
  • 3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on Central Trust Company's 13F filing for Q4 2025, filed 2 Feb 2026.